Can I read HOME VII consensus decisions for measuring eczema control, quality of life and itch intensity on EtoBox?

HOME VII consensus decisions for measuring eczema control, quality of life and itch intensity is a Medicine article available to read on EtoBox.

What is HOME VII consensus decisions for measuring eczema control, quality of life and itch intensity about?

The Harmonising Outcome Measures for Eczema (HOME) initiative is an international collaboration involving people with eczema, health professionals, researchers, regulators and industry representatives. The collaboration is working globally to agree a defined list of aspects of eczema that should be measured in all future eczema clinical trials and systematic reviews. At previous international consensus meetings, collaborators have agreed what aspects of eczema (also called dermatitis) are important to capture, and how clinical signs of eczema and eczema symptoms should be measured. The HOME VII consensus meeting, held in Japan in April 2019, involved 74 participants from around the world and aimed to agree how best to measure quality of life, long-term eczema control and itch intensity. Following whole and small group discussions and anonymous keypad voting over 3 days, agreement was reached on the preferred measurement instruments to be used to capture patient-reported outcomes of quality of life, eczema control and itch intensity. For now, the core outcome set for clinical trials in atopic eczema is complete and can be used by researchers around the world to improve consistency i

Who reads HOME VII consensus decisions for measuring eczema control, quality of life and itch intensity?

Publisher

Oxford University Press (OUP)

Published

2021

Language

EN

Field

Medicine (Health Sciences)